Page 15 - Michael Erman News Today

By Michael Erman and Deena Beasley NEW YORK (Reuters) -The U.S. Food and Drug Administration has been looking into 22 cases of T-cell cancers that occurred ...

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will...

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk's Wegovy and Zepbound from Eli Lilly. Amgen has an experimental dual mechanism obesity drug in mid-stage trials it hopes will have fewer side effects with less frequent dosing than Wegovy or Zepbound, Chief Scientific Officer Jay Bradner told Reuters at the annual JPMorgan health conference in San F...

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisks...

By Michael Erman NEW YORK (Reuters) -Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile ...

Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed...

NEW YORK (Reuters) -Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors. The expected price hikes come as the pharmaceutical industry gears up for the Biden Administration to publish significantly discounted prices for 10 high-cost drugs in September, and continues to contend with higher inflation and manufacturing costs. Under Pres...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...

By Michael Erman and Patrick Wingrove NEW YORK (Reuters) - Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the U...